Sciformix Announces Expansion into Europe with New Office in UK

European office to support growth in client delivery and customer support

6 January 2015, Boston, MA – Sciformix Corporation, a leading Scientific Process Organization (SPO), has opened a new office in Manchester, UK expanding its global presence and footprint to include the European region. For more than 7 years, Sciformix has been supporting life science organizations with high quality services in the areas of safety and risk management, regulatory affairs and operations and clinical research and post-approval support. The opening of the new European office demonstrates Sciformix’ scalability and preparedness to combine optimized on-shore/off-shore models that enhance client value and experience while maximizing cost benefits.

By opening an office in the UK, Sciformix will seek to better service its existing global and European clients with near-shore presence and also build new relationships with potential clients across EMEA to further grow and diversify its client and revenue base. Sciformix’s unique combination of expert talent, LEAN processes, technology innovation and flexible operations provides an attractive option to life science organizations, small and large, who are seeking to establish strategic outsourcing partnerships.

With this expansion into Europe to complement its already established presence in the United States and Asia with over 750 employees, Sciformix will be within arm’s reach of the clients’ operations across 3 continents. With delivery functions operating also out of the European Union (EU), clients will experience Sciformix even more as an extension of their own operations.

For years, industry groups have lobbied the UK government to help establish and nurture a life sciences hub, similar to that in Boston, USA where world-class research institutions abut promising biotech start-ups and Big Pharma. The UK is now striving to brand itself as a hotbed for biotech R&D, promising new funds for start-ups, pledging to speed up its approval process and courting some major players to deepen their roots in the country. Sciformix will be able to take advantage of this and play a key role in this growth.

Manish Soman, President & CEO, Sciformix Corporation commented, “Sciformix’s long term strategy focuses on evolving and enhancing our service and technology offerings, broadening our global reach and growing and diversifying the client and revenue base. Building a European hub will support all of these objectives. With our clients’ growth in emerging markets, it has become increasingly important for us to truly understand the local safety and regulatory challenges our clients face and to become the partner of choice when it comes to outsourcing these activities. Sciformix is such a trusted provider.”

The new office will support all service lines, however, the initial focus will be on Consulting, Safety and Risk Management, Regulatory, and Labelling services.

To learn more about Sciformix visit , email us at, or call us at +1.877.576.5005.

For further press information please contact: Vanessa Wright, The Scott Partnership: + 44 1477 539539 mail to or Susan Najjar, Director of Marketing, Sciformix Corporation: + 1 617-264-0339 mail to

About Sciformix

Sciformix Corporation is a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical and biopharmaceutical, generics, consumer products, medical devices and other healthcare companies – in the areas of Safety and Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs.  Our mission is to partner with global life science companies to provide high quality scientific knowledge-based expertise to deliver better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving quality of healthcare for patients worldwide. Corporate headquarters is located in Westborough, MA with operations in USA, India and the Philippines.

We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, industry reputed advisory board, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.

Sciformix is dedicated to providing our clients outstanding services and solutions, fuelled by an unrivalled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team.  Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results.  Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science.